Public annual accounts

DNA Solutions financials

Name: DNA Solutions financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DNA Solutions, with comparable measures and links to available source documents.

Company overview

Registry number

0812138933

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for DNA Solutions

2025 versus 2024

Operating line: €115,715
EBITDA: €113,114
Total assets: €555,192
Equity: €262,052

EBITDA margin +97.8% · Equity ratio +47.2%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Sept 2025	€115,715	€113,114	€555,192	€262,052	-
202430 Sept 2024	€78,639	€75,699	€564,643	€226,558	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report